| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Acasti Pharma Inc. | Director | Stock Options (Right to Buy) | 42,100 | 12 Nov 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GRCE | Acasti Pharma Inc. | 12 Nov 2021 | 1 | $0 | 4 | Director | 16 Nov 2021, 15:17 |